Summary of Study ST002261

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001443. The data can be accessed directly via it's Project DOI: 10.21228/M86H66 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002261
Study TitleInvestigating metabolic pathways of pediatric obesity (urine)
Study SummaryThe pediatric obesity influences all the organs and is closely linked to an increased risk of diverse diseases such as diabetes, cardiovascular, stroke, social problems and depression. Therefore, there is needed to diverse study for effective methods for the prevention and treatment of pediatric obesity. Diverse evidences suggest that gut microbiome and its metabolites affect metabolic disease such as obesity, diabetes, and heart disease. Previous studies in human and fecal transplantation experiments in animal models identified connections between the metabolic diseases and gut microbiota [4]. Moreover, metabolites can be fulfilled as diagnostic, prognostic, and therapeutic targets for diseases. Thus, approaches using metagenomics and metabolomics have the potential to provide new insights into metabolomic pathways of the diseases and help personalized and efficient treatments. In this study, we aimed to investigate metabolomic pathways of pediatric obesity analyzing both metabolome and microbiome profiles. In addition, we proceeded obese intervention with obese children to examine underlying metabolomic pathways related to effect of the intervention.
Institute
Seoul National University College of Medicine and Hospital
DepartmentDepartment of Clinical Pharmacology and Therapeutics
Last NameLee
First NameYujin
Address101 Daehak-ro, Jongno-gu, Seoul 110-799, Korea, Seoul, Seoul, 03080, Korea, South
Emailyoojinlee@snu.ac.kr
Phone+82-10-3380-4686
Submit Date2022-07-04
Raw Data AvailableYes
Raw Data File Type(s)smp
Analysis Type DetailGC-MS
Release Date2023-01-04
Release Version1
Yujin Lee Yujin Lee
https://dx.doi.org/10.21228/M86H66
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN003694
Analysis type MS
Chromatography type GC
Chromatography system Agilent 7890B
Column Restek Rtx-5Sil (30m x 0.25mm,0.25um)
MS Type EI
MS instrument type GC-TOF
MS instrument name Leco Pegasus HT TOF
Ion Mode NEGATIVE
Units intensity

MS:

MS ID:MS003445
Analysis ID:AN003694
Instrument Name:Leco Pegasus HT TOF
Instrument Type:GC-TOF
MS Type:EI
MS Comments:The LECO Corporation ChromaTOF®-GC software (v4.72) was used for data acquisition and extraction. This included computation of baseline (offset of 1; above the noise) and automatic entering the number of data points for smoothing. The software's Statistical Compare was used to align peaks. The MS spectral matching was performed using the NIST and Wiley9 libraries. Also, retention index method was used for identification.
Ion Mode:NEGATIVE
  logo